Teva Appeals Patent Case of MS Drug Copaxone

Apr 02, 2014

Huffington Post

Supreme Court justices agreed to hear an appeal from Teva Pharmaceutical Industries Ltd., which claims the U.S. Court of Appeals for the Federal Circuit wrongly overturned five of its patents for the drug Copaxone. The appeals court ruling would allow rivals Mylan Inc., Momenta Pharmaceuticals Inc. and Sandoz Inc., to start selling generic versions of the drug later this year, after the remaining patents on the drug expire. Read the full story


Join the discussion

We welcome your thoughtful comments. Please comply with our Community rules.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments